Molecular detection of circulating β-cells after islet transplantation

Diabetes

Volumn 51, Issue 3, 2002, Pages 557-561

  Ritz Laser, Beate ^a   Oberholzer, José ^a   Toso, Christian ^a   Brulhart, Marie Claude ^a   Zakrzewska, Katerina ^a   Ris, Frédéric ^a   Bucher, Pascal ^a   Morel, Philippe ^a   Philippe, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INSULIN; MESSENGER RNA;

ADULT; AGED; ALLOIMMUNITY; ARTICLE; AUTOIMMUNITY; CELL DAMAGE; CELL LOSS; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISSOCIATION; DRUG INDUCED DISEASE; EARLY DIAGNOSIS; FEMALE; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOLECULAR DYNAMICS; MULTIPLE TRAUMA; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036313598     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.557     Document Type: Article

References (23)

1. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
2. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol
3. Recent developments and future prospects in pancreatic and islet transplantation
4. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts
5. Novel approaches toward early diagnosis of islet allograft rejection
6. Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient
7. Morphological and functional changes following intraportal islet allograft rejection: Irreversibility with steroid pulse therapy
8. Human islet transplantation: Lessons from 13 autologous and 13 allogeneic transplantations
9. Transplantation of the islets of Langerhans: New hope for treatment of type 1 diabetes mellitus
10. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation
11. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
12. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood
13. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine
14. Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management
15. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans
16. Revascularization and microcirculation of freely grafted islets of langerhans
17. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications clinical intraportal islet ti ansplantation?
18. Human islet amyloid polypeptide (IAPP) oligomers disrupt integrity of human islets: A proposed novel mechanism of hIAPP toxicity
19. Vulnerability of islets in the immediate posttransplantation period: Dynamic changes in structure and function
20. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice
21. Prevention of detrimental effect of cyclosporin A on vascular ingrowth of transplanted pancreatic islets with verapamil
22. Surviving native beta-cells determine outcome of syngeneic traportal islet transplantation